Maria Isabel
Maria Isabel Abadias Sero, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20130280226 | BIOLOGICAL CULTURE OF A STRAIN OF THE PSEUDOMONAS GRAMINI SPECIES, USE OF SAID CULTURE AS ANTAGONIST FOR BIOLOGICAL CONTROL OF PATHOGENIC BACTERIA, AND METHOD FOR TREATING FRUIT THAT COMPRISES THE STEP OF APPLYING, TO THE FRUIT, A PREPARATION THAT COMPRISES SAID CULTURE - Substantially pure biological culture of a strain of the species | 10-24-2013 |
Maria Isabel Arroyo Villan, Tarragona ES
Patent application number | Description | Published |
---|---|---|
20100075079 | OZONE RESISTANT COMPOSITIONS AND ARTICLES - The invention relates to a composition comprising a propylene-based interpolymer and a saturated compound selected from the group consisting of aliphatic amides, hydrocarbon waxes, hydrocarbon oils, fluorinated hydrocarbons, and siloxanes, and wherein the propylene-based interpolymer comprises (a) greater than 50 mole percent propylene, based on the total moles of polymerizable monomers, and (b) ethylene, or ethylene and more unsaturated comonomers, or one or more unsaturated comonomers, and wherein the propylene-based interpolymer has at least one of the following properties: (i) 13C NMR peaks corresponding to a regio-error at about 14.6 and about 15.7 ppm, the peaks of about equal intensity, and (ii) a DSC curve with a Tme that remains essentially the same, and a TMax that decreases as the amount of comonomer in the interpolymer is increased. The invention also provides for articles, such as films, comprising at least one component formed from an inventive composition, and for methods of making the same. | 03-25-2010 |
20100291344 | COATED SUBSTRATES AND PACKAGES PREPARED THEREFROM - The invention relates to a perforated coated substrate comprising at least the following: i) a first layer, ii) a second layer, and iii) a woven and/or nonwoven web; and wherein the second layer has a lower softening and/or melting temperature, as compared with the respective softening and/or melting temperatures of the first layer, and the respective softening and/or melting temperatures of the web; and wherein the layers of the coated substrate have perforations with a common center. | 11-18-2010 |
20110097564 | FILMS, ARTICLES PREPARED THEREFROM, AND METHODS OF MAKING THE SAME - The invention provides a film comprising at least three layers, one inner layer adjacent to two outer layers, and wherein at least one inner layer is formed from a composition comprising an ethylene-based polymer with a density greater than, or equal to, 0.945 g/cc or a cyclic olefin copolymer; and wherein each outer layer is, independently, formed from a composition comprising a propylene-based polymer; and wherein the at least one inner layer is less than, or equal to, 25 percent of the total film thickness. | 04-28-2011 |
20120094563 | COATED SUBSTRATES AND PACKAGES PREPARED THEREFROM - The invention provides a coated substrate comprising at least the following: i) a first layer formed from a first composition that has a melting point, Tm1, and comprising at least one ethylene-based interpolymer; ii) a second layer formed from a second composition comprising the following: a) at least one propylene-based polymer, and b) at least one ethylene-based polymer, and iii) a woven web formed from at least one olefin-based polymer with a melting point of Tm2a and/a or nonwoven web formed from at least one olefin-based polymer with a melting point of Tm2b; and wherein and Tm1 is less than, or equal to, “Tm2a −20° C.”, and/or less than, or equal to, “Tm2b −20° C.” The invention also provides a coated substrate comprising at least the following: i) a first layer is formed from a first composition that has a melting point, Tm1; and ii) a woven web formed from at least one olefin-based polymer with a melting point of Tm2a and/or a nonwoven web formed from at least one olefin-based polymer with a melting point of Tm2b; and wherein and the first composition comprises at least one propylene-based polymer with a MFR from 15 to 35 g/10 min, and wherein Tm1 is less than, or equal to, “Tm2a −20° C.”, and/or less than, or equal to, “Tm2b −20° C.” | 04-19-2012 |
20150328865 | Flexible Film Composition for Heat Seals and Container with Same - The present disclosure is directed to compositions and film structures suitable for heat seal production. The heat sealable flexible film structure includes: a layer (A) comprising a propylene-based plastomer or elastomer (“PBPE”) and a low density polyethylene; a layer (B), adjacent to layer (A), comprising at least 50 percent by weight of the layer (B) of an ethylene-based polymer; and an outermost layer (C) comprising a material having a melting point greater than 140° C. Weight percents are based on the total weight of the respective layer. The heat sealable flexible film structure is used to make a flexible container ( | 11-19-2015 |
Maria Isabel Arroyo Yillan, Tarragona ES
Patent application number | Description | Published |
---|---|---|
20130305664 | COATED FABRIC, A BAG PRODUCED THEREFROM, A PACKAGING MACHINE FOR BAGS AND A METHOD FOR FILLING THE BAGS - A coated fabric ( | 11-21-2013 |
Maria Isabel Barriguete Díez, Madrid ES
Patent application number | Description | Published |
---|---|---|
20120023942 | METHOD FOR INCREASING THE NET ELECTRIC POWER OF SOLAR THERMAL POWER STATIONS - The present invention allows increasing the net electric power supplied to the network by the solar thermal power plants of the cylindrical parabolic collector type by using the solar field in a more efficient manner, generating steam to drive the main ancillaries by means of steam turbines (turbo pumps), reducing electric consumption of the ancillary services and therefore increasing the net electric power of the plant. | 02-02-2012 |
Maria Isabel Beltran Rico, Alicante ES
Patent application number | Description | Published |
---|---|---|
20150320108 | ALUMINOSILICATE SAB-15 AS AN ADDITIVE FOR REDUCING THE TOXIC AND CARCINOGENIC COMPOUNDS PRESENT IN TOBACCO SMOKE - The invention relates to the use of the aluminosilicate SAB-15, or the acidic or sodic forms thereof, interchanged with Fe, Na, K, Ca, Ce, Zr, the oxides of Fe, Na, K, Ca, Ce, Zr, and mixtures of same as an additive for reducing the toxic and carcinogenic substances present in tobacco smoke. | 11-12-2015 |
Maria Isabel Carrizales, New York, NY US
Patent application number | Description | Published |
---|---|---|
20110125677 | Decorated Products - Decorated products, such as toothbrushes, of substantially the same type and having substantially the same features (preferably functional features) except for a decorative element. The decorative element on each product is selected from a plurality of different decorative elements such that the products may be visually or aesthetically differentiated from one another by the differences in the decorative element associated therewith, while otherwise having the same functional characteristics. An exemplary embodiment is sleeved adult toothbrushes, the sleeves each having one of a variety of designs, the set of available designs including designs of different categories to appeal to different consumer bases (e.g., different ages, genders, styles, etc.) or to signal a time period for use of the product (e.g., a variety of designs for each of the four seasons to signal changing the toothbrush each season). Preferably, the products are decorated with a design selected from more than one category of designs, at least two of which categories include more than one design. The designs may be changed for the product line on a regular or semi-regular basis to refresh the appearance of the products. | 05-26-2011 |
20140116463 | DECORATED PRODUCTS - Decorated products, such as toothbrushes, of substantially the same type and having substantially the same features (preferably functional features) except for a decorative element. The decorative element on each product is selected from a plurality of different decorative elements such that the products may be visually or aesthetically differentiated from one another by the differences in the decorative element associated therewith, while otherwise having the same functional characteristics. An exemplary embodiment is sleeved adult toothbrushes, the sleeves each having one of a variety of designs, the set of available designs including designs of different categories to appeal to different consumer bases (e.g., different ages, genders, styles, etc.) or to signal a time period for use of the product (e.g., a variety of designs for each of the four seasons to signal changing the toothbrush each season). | 05-01-2014 |
Maria Isabel Clemente Mayoral, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100034789 | Novel carbosilane dendrimers, preparation method thereof and use of same - Novel carbosilane dendrimers, their preparation and their uses. The dendrimers of the invention have secondary, tertiary and quaternary amino groups at their branch ends. Their possible uses include vehicles for carrying anionic-charged molecules in the blood, such as nucleic acids, among them ODN and RNAi, and other anionic drugs with which they have the capacity of interacting, protecting them from interaction with plasma protein and/or increasing their penetration rate in target cells. In the cases where the bond is long-lasting, the dendrimers of the invention can be used to fix anionic molecules to surfaces. Their uses also include their administration as active ingredients to prevent or treat diseases caused by micro-organisms with whose structure and/or life cycle they interfere. | 02-11-2010 |
Maria Isabel Cordero Marcos, Espoo FI
Patent application number | Description | Published |
---|---|---|
20140275702 | Method and Apparatus for Using a Designated Patient Structure as an Area to be Masked From Radiation - A control circuit provides a user with an opportunity to designate one or more patient structures for a particular patient that are to be protected from radiation. When optimizing a radiation-treatment plan for that patient, then, the control circuit uses the designated patient structure(s) as an area to be masked from radiation during administration of the radiation-treatment plan. By one approach the aforementioned opportunity to designate patient structures as being designated patient structures comprises providing the user with an opportunity to so designate patient structures via a display. The aforementioned masking can be accomplished as desired including by appropriate use of a multi-leaf collimator. | 09-18-2014 |
20150095043 | AUTOMATIC CREATION AND SELECTION OF DOSE PREDICTION MODELS FOR TREATMENT PLANS - A dose prediction model can be determined for generating a dose distribution of a treatment plan for irradiating a target structure within a patient. Treatment plans from previous patients can be analyzed to determine D characteristic values to obtain a D dimensional point for each treatment plan. The treatment plans can be clustered based on the D dimensional points. The treatment plans of a cluster can then be used to determine a dose prediction model. A dose prediction model for patient can be selected from among multiple models. Characteristics about the patient can be used to determine a D dimensional point corresponding to the patient. The D-dimensional point can be used to select a model in comparison to D dimensional points of the models. | 04-02-2015 |
20150095044 | DECISION SUPPORT TOOL FOR CHOOSING TREATMENT PLANS - Patient data can be used to determine input values to different estimation functions for different treatment types. The estimation functions can each be used to estimate one or more outcome values for the respective treatment. A quality score can be determined using the outcome value(s). A first treatment plan having an optimal quality score can be identified, e.g., by displaying the treatment plans with the quality scores, which may correspond to the outcome values. | 04-02-2015 |
Maria Isabel Covas Planells, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20130267588 | HYDROXYTYROSOL ETHERS - The invention relates to hydroxytyrosol ethers derived from fatty alcohols and phenolic compounds of olive oil and the salts, solvates and hydrates thereof, which have an affinity for type 1 cannabinoid receptors (CB1) and which can: prevent the oxidation of low-density lipoprotein (LDL); and modulate the actions regulated by said receptor, such as inducing satiety, controlling intake and reducing body fat. | 10-10-2013 |
Maria Isabel Crespo Crespo, Barcelona ES
Patent application number | Description | Published |
---|---|---|
20090042933 | Derivatives of 4-(2-amino -1-hydroxyethyl)phenol as agonists of the Beta2 adrenergic receptor - A compound of formula (I) or a pharmaceutically-acceptable salt, solvate or stereoisomer thereof wherein R | 02-12-2009 |
20110028442 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL) PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the β2 adrenergic receptor. | 02-03-2011 |
20110251165 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
20110251166 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present invention provides a compound of formula (I) wherein: R | 10-13-2011 |
20120101075 | Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 Adrenergic Receptor - The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the BETA2 adrenergic receptor. | 04-26-2012 |
20120115826 | Derivatives of 4-(2-Amino-1-Hydroxyethyl) Phenol as Agonists of the Beta2 AdrenergicReceptor - The present disclosure relates to 4-(2-amino-1-hydroxyethyl)phenol derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the BETA2 adrenergic receptor. | 05-10-2012 |
20150210643 | DERIVATIVES OF 4-(2-AMINO-1-HYDROXYETHYL)PHENOL AS AGONISTS OF THE BETA2 ADRENERGIC RECEPTOR - The present relates to compounds of formula (I): | 07-30-2015 |
Maria Isabel Garcia Aranda, Toledo ES
Patent application number | Description | Published |
---|---|---|
20140107334 | PROCESS FOR THE SYNTHESIS OF 3-(2-BROMO-4,5-DIMETHOXYPHENYL)PROPANENITRILE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID - Process for the synthesis of the compound of formula (I): | 04-17-2014 |
20140128598 | PROCESS FOR THE SYNTHESIS OF (2E)-3-(3,4-DIMETHOXYPHENYL)PROP-2-ENENITRILE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID - Process for the synthesis of the compound of formula (I): | 05-08-2014 |
20140163220 | PROCESS FOR THE SYNTHESIS OF 3-(2-BROMO-4,5-DIMETHOXYPHENYL)PROPANENITRILE, AND APPLICATION IN THE SYNTHESIS OF IVABRADINE AND ADDITION SALTS THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE ACID - Process for the synthesis of the compound of formula (I): | 06-12-2014 |
Maria Isabel Garcia-Cruz, Monterrey MX
Patent application number | Description | Published |
---|---|---|
20130216488 | ANTIMICROBIAL, ANTIBACTERIAL AND SPORE GERMINATION INHIBITING ACTIVITY FROM AN AVOCADO EXTRACT ENRICHED IN BIOACTIVE COMPOUNDS - The present disclosure relates to extracts from | 08-22-2013 |
Maria Isabel Gimeno Verdejo, Zaragoza ES
Patent application number | Description | Published |
---|---|---|
20130285340 | SHOPPING BASKET - The present invention disclosure relates to a shopping basket intended for being coupled on a larger second shopping basket of the type having wheels and steered by means of a pulling handle, and basically comprising a one-piece body with a front wall, a rear wall, two side walls and a bottom, and anchoring means intended for securing it on the lower basket, preventing it from tipping over. | 10-31-2013 |
20140210171 | BASKET - A basket for public use includes a substantially upright tapered body for repeatedly moving purchasable items within a store; the body includes an interior space and an open top; the open top permits access to the interior for placing the plurality of purchasable items in the interior. Wheels allow rolling the basket within the store and a telescoping handle provided on a face of the body rollingly pulls the basket. A like-basket is nestable in the basket in a first and a second position; eg the telescoping handles are proximate to each other or the telescoping handles are distal from each other. | 07-31-2014 |
Maria Isabel Gomez, Hallandale Beach, FL US
Patent application number | Description | Published |
---|---|---|
20150271013 | Ubiquitous Collaboration In Managed Applications - Methods and systems for an ubiquitous collaboration feature in a managed application environment are described herein. The collaboration service and/or server may store session information and one or more configuration files for use in rendering the collaboration features in combination with managed applications executing on a user's computing device. | 09-24-2015 |
Maria Isabel Gomez-Orellana, New Rochelle, NY US
Patent application number | Description | Published |
---|---|---|
20080255250 | Compounds and Compositions for Delivering Active Agents - Compounds and compositions for the delivery of active agents are provided. Methods of administration and preparation are provided as well. | 10-16-2008 |
Maria Isabel Jimenez Alonso, Madrid ES
Patent application number | Description | Published |
---|---|---|
20080248473 | Method and Kit for the Detection of Bacterial Species by Means of Dna Analysis - The present invention relates to the detection and identification of different bacterial species, all of which cause zoonosis, based on DNA analysis. More specifically, the invention provides the primers, probes, genes and genic regions required to apply a method for the simultaneous detection of bacteria and bacterial groups belonging to the genera | 10-09-2008 |
20110104696 | KIT FOR DETECTION OF BACTERIAL SPECIES BY MEANS OF DNA ANALYSIS - The present invention relates to the detection and identification of different bacterial species, all of which cause zoonosis, based on DNA analysis. More specifically, the invention provides the primers, probes, genes and genic regions required to apply a method for the simultaneous detection of bacteria and bacterial groups belonging to the genera | 05-05-2011 |
Maria Isabel López Román, Madrid ES
Patent application number | Description | Published |
---|---|---|
20110219473 | PEDICEL SPECIFIC PROMOTER - The present invention relates to controlling the expression of genes into the pedicel, more specifically in the placentochalaza cells. | 09-08-2011 |
Maria Isabel Lopez-Sanchez, Guadalajara MX
Patent application number | Description | Published |
---|---|---|
20110098354 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and, a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
20110098355 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 04-28-2011 |
20110105605 | METHOD OF PREPARING A LATANOPROST OPHTHALMIC SOLUTION AND THE RESULTING SOLUTION - A method of solubilizing an analog active agent of the prostaglandin F2α, such as latanoprost, is described and a method of preparing an ophthalmic solution of the solubilized latanoprost for the treatment of distinct ocular ailments. This invention also refers to an ophthalmic aqueous solution resulting from the aforementioned method, which is characterized by its chemical stability at room temperature, its safety, and innocuousness and efficiency in the treatment of the patient. The new ophthalmic aqueous solution is distinguished because its pharmaceutical value is found in the handling of a vehicle of easy access that not only permits the solubility of latanoprost, but also promotes its chemical stability and a greater tolerance of the patient with its ophthalmic application for the treatment of the patient's ailment. | 05-05-2011 |
Maria Isabel Lorza, St. Augustine, FL US
Patent application number | Description | Published |
---|---|---|
20110184448 | LANCING DEVICE - A lancing device formed from a main body and a cap. The main body is configured from a lower housing, an upper housing extending over a portion of the lower housing, and an actuator operatively engaged to the upper and lower housings with the actuator extending along the portion of the lower housing not covered by the upper housing. The upper housing further includes an actuator button, wherein a lancet may be placed within the body such that movement of the actuator from a first position to a second position away from said endcap cocks the lancet for firing, which is achieved by depressing the actuator button. Conveniently, the lancing device is configured for tactile recognition in the palm of a human hand and may preferably be operated one handed and without visual observation. | 07-28-2011 |
Maria Isabel Loza Garcia, Santiago De Compostela ES
Patent application number | Description | Published |
---|---|---|
20110065138 | Quantitative Method For Detecting Yessotoxins In Fishery Products On Based On The Activation That The Toxin Produces In Cellular Phosphodiesterases And Therapeutic Use Of This Activation - The present invention relates to a quantitative method for detecting yessotoxins in fishery products based on the activation the toxin produces on cellular phosphodiesterases and the therapeutic use of this activation. The cellular target of yessotoxin (YTX) and its analogs is the activation of phosphodiesterases (PDEs). The PDEs-YTX bond produces a measurable signal. The bond can be quantified by means of an affinity biosensor or by fluorescence. The biosensor detects biomolecular interactions and allows determining the presence of YTX due to its interaction with PDEs. The variations in the degradation rate of the fluorescent derivative anthraniloyl-cAMP are determined by means of plate fluorescence. The rate at which the PDEs degrade this molecule increases in the presence of YTX. YTX inhibits immunological activation of mastocytes in rats and induces a cytotoxic effect in human hepatocarcinoma cells, which implies two therapeutic uses of YTXs as an antiallergic and antitumor compound. | 03-17-2011 |
Maria Isabel Martin Fontelles, Madrid ES
Patent application number | Description | Published |
---|---|---|
20140107111 | USE OF SIGMA LIGANDS IN DIABETES TYPE-2 ASSOCIATED PAIN - The invention refers to the use of a sigma ligand, particularly a sigma ligand of formula (I) to prevent and/or treat type-2 diabetes-associated pain and related symptoms. | 04-17-2014 |
Maria Isabel Moreira Da Costa Franco, Ermesinde PT
Patent application number | Description | Published |
---|---|---|
20100028489 | PRE-FERMENTED SYMBIOTIC MATRIX BASED ON A CEREAL SUSPENSION WITH ENCAPSULATED PROBIOTICS, MANUFACTURE PROCESS AND CORRESPONDING UTILIZATION - The present invention is about a pre-fermented symbiotic matrix based on a cereal suspension, preferably oat, containing encapsulated probiotics and prebiotics, the manufacturing process and the corresponding utilization. The present invention's object is the development of a cereal symbiotic matrix, preferably from oat, pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics, with the aim of complementing the actual functional food market and solving problems inherent to the reduced shelf-life period of such foods due to loss of probiotic viability to values below the minimum limits needed in order to promote biological activity. Furthermore, the present invention's object is to improve the fermentative process conditions at different levels, namely fermentation time reduction in order to reduce energy consumption during the process and the risk of contamination reduction as well as promote long term microbial stability maintenance. The pre-fermented symbiotic matrix is designed, in particular, for those cases where intolerance and/or allergy to dairy products occur, yet it is further applicable to the pharmaceutical, cosmetic and preferably food industries, including pet food. | 02-04-2010 |
20150071891 | PRE-FERMENTED SYMBIOTIC MATRIX BASED ON A CEREAL SUSPENSION WITH ENCAPSULATED PROBIOTICS, MANUFACTURE PROCESS AND CORRESPONDING UTILIZATION - A pre-fermented symbiotic matrix based on a cereal suspension (e.g., oat) containing encapsulated probiotics and prebiotics is pre-fermented with encapsulated probiotics and free and/or encapsulated prebiotics. | 03-12-2015 |
Maria Isabel Osendi, Madrid ES
Patent application number | Description | Published |
---|---|---|
20150246851 | Process For Production Of Graphene/Silicon Carbide Ceramic Composites - We provide a method for the in situ development of graphene containing silicon carbide (SiC) matrix ceramic composites, and more particularly to the in situ graphene growth within the bulk ceramic through a single-step approach during SiC ceramics densification using an electric current activated/assisted sintering (ECAS) technique. This approach allows processing dense, robust, highly electrical conducting and well dispersed nanocomposites having a percolated graphene network, eliminating the handling of potentially hazardous nanostructures. Graphene/SiC components could be used in technological applications under strong demanding conditions where good electrical, thermal, mechanical and/or tribological properties are required, such as micro and nanoelectromechanical systems (MEMS and NEMS), sensors, actuators, heat exchangers, breaks, components for engines, armours, cutting tools, microturbines or microrotors. | 09-03-2015 |
Maria Isabel Parra-Calvache, Amsterdam NL
Patent application number | Description | Published |
---|---|---|
20100326133 | METHOD AND APPARATUS FOR COOLING DOWN A CRYOGENIC HEAT EXCHANGER AND METHOD OF LIQUEFYING A HYDROCARBON STREAM - Method and apparatus for cooling down a cryogenic heat exchanger, employing a programmable controller that receives input signals representing sensor signals of one or more controlled variables in a selected process, and produces control signals to control one or more manipulated variables in the selected process. The programmable controller can execute a computer program that comprises a network of at least three modules. The modules in the network are interconnected such a trigger signal received by a second and a third module of the at least three modules corresponds to a communication signal that is generated when the first module of the at least three modules has reached a pre-determined target for that module. | 12-30-2010 |
Maria Isabel Rodriguez Franco, Madrid ES
Patent application number | Description | Published |
---|---|---|
20100305157 | DERIVATIVES OF DICARBOXYLIC AMINO ACIDS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES - Products of a general formula (I) and their use in the manufacture of medicines useful for the treatment of neurodegenerative diseases such as Alzheimer's disease or, in general, any disease or pathology produced by alterations of biological functions that can be treated or therapeutically modified by these products. | 12-02-2010 |
Maria Isabel Rozas Hernando, Dublin IE
Patent application number | Description | Published |
---|---|---|
20100160332 | a2-Adrenoceptor Ligands - The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel compounds which are ligands of the alpha2-adrenoceptor (α | 06-24-2010 |
20100331384 | GUANIDINE BASED COMPOUNDS - The adrenergic receptors or adrenoceptors are a family of G-protein coupled receptors split into α and β subclasses. The adrenoceptors have important roles in regulating a myriad of physiological conditions and their malfunction has been implicated in the pathophysiology of a number of diseases. Disclosed herein are a series of novel guanidine and 2-aminoimidazoline compounds which are ligands of the alpha2-adrenoceptor (α2-ARs) subclass of adrenergic receptors. The invention also provides for pharmaceutical compositions comprising the novel compounds. The compounds are suitable for use in the manufacture of medicaments for the treatment of α2-ARs associated disorders, such as depression, schizophrenia, glaucoma and analgesia. | 12-30-2010 |
Maria Isabel Sanchez Zarzoso, Salamanca ES
Patent application number | Description | Published |
---|---|---|
20090208610 | PIZZA - The invention relates to an improved pizza in which a dough grid arises from its dough base, which grid is made of the same dough and completely covers the surface of the pizza occupied by the components, preventing the latter from being separated therefrom. | 08-20-2009 |
Maria Isabel Santacruz, Leicestershire GB
Patent application number | Description | Published |
---|---|---|
20090294357 | Method for Concentrating Nanosuspensions - A method for concentrating a nanosuspension including nanopowder particles suspended in a liquid includes reducing the liquid content of the nanosuspension and controlling the dispersion of the nanopowder particles in the liquid. | 12-03-2009 |
Maria Isabel Santos Benitez, Badajoz ES
Patent application number | Description | Published |
---|---|---|
20160120714 | LUMINOUS SIGNALLING DEVICE FOR SIGNALLING PRESENCE ON PEDESTRIAN CROSSINGS - The invention relates to a box of insulating material which houses a strip of lilac LEDs, said strip being programmed to operate as a flickering light and being electrically powered by batteries, said box being attached to the sides or wheels of a transport means such as a wheelchair, a pram, a bicycle or the like, by means of a fastening means such as nuts and bolts, velcro or other such suitable means, said fastening means being in the rear area of the box. | 05-05-2016 |
Maria Isabel Tamargo, Philadelphia, PA US
Patent application number | Description | Published |
---|---|---|
20110230566 | PERFLUOROCARBON EYE CREAM FORMULATIONS - Disclosed are perfluorocarbon compositions for cosmetic applications, in particular, for application to the periocular skin, and methods for using the same. | 09-22-2011 |
María Isabel Gil Muñoz, Espinardo (murcia) ES
Patent application number | Description | Published |
---|---|---|
20130266932 | METHOD AND ASSOCIATED SYSTEM FOR DETECTION AND ANALYSIS OF PATHOGENS AND/OR AGENTS ABLE TO CAUSE DETERIORATION IN PLANT FOODS - The present invention relates to a method for the detection of potentially pathogenic agents and/or capable of causing deterioration in a plant sample, representative of one or several batches of plant product, characterized in that it comprises the concentration of a plant sample by centrifugation and the analysis of the presence or amount of potentially pathogenic agents and/or capable of causing deterioration in the concentrated sample obtained. Likewise, the present invention relates to a system for detection and analysis of potentially pathogenic agents and/or capable of causing deterioration in a plant sample to carry out said method. | 10-10-2013 |
María Isabel Gil Muñoz, Espinardo (murcia) ES
Patent application number | Description | Published |
---|---|---|
20130266932 | METHOD AND ASSOCIATED SYSTEM FOR DETECTION AND ANALYSIS OF PATHOGENS AND/OR AGENTS ABLE TO CAUSE DETERIORATION IN PLANT FOODS - The present invention relates to a method for the detection of potentially pathogenic agents and/or capable of causing deterioration in a plant sample, representative of one or several batches of plant product, characterized in that it comprises the concentration of a plant sample by centrifugation and the analysis of the presence or amount of potentially pathogenic agents and/or capable of causing deterioration in the concentrated sample obtained. Likewise, the present invention relates to a system for detection and analysis of potentially pathogenic agents and/or capable of causing deterioration in a plant sample to carry out said method. | 10-10-2013 |
María Isabel González Siso, A Coruna ES
Patent application number | Description | Published |
---|---|---|
20130273602 | STRAINS OF S.CEREVISIAE CAPABLE OF GROWING IN MEDIA WITH MELIBIOSE, STACHYOSE AND RAFFINOSE - The invention relates to strains of | 10-17-2013 |
20150031078 | KLUYVEROMYCES LACTIS YEAST STRAIN AND METHODS FOR THE PRODUCTION OF SUGARS, ETHANOL, BETA-GALACTOSIDASE AND BIOMASS - The present invention is a | 01-29-2015 |
María Isabel González Siso, A Coruna ES
Patent application number | Description | Published |
---|---|---|
20130273602 | STRAINS OF S.CEREVISIAE CAPABLE OF GROWING IN MEDIA WITH MELIBIOSE, STACHYOSE AND RAFFINOSE - The invention relates to strains of | 10-17-2013 |
María Isabel Loza Garcia, Santiago De Compostela (a Coruna) ES
Patent application number | Description | Published |
---|---|---|
20120225879 | SUBSTITUTED 5-IMINO-1,2,4-THIADIAZOLES THAT CAN BE USED TO TREAT NEURODEGENERATIVE DISEASES - The present invention is based on the use of a broad family of 5-imino-1,2,4-thiadiazoles as potential new drugs for the treatment of diseases in which PDE7 inhibition is important, specially inflammatory diseases, autoimmune and neurodegenerative disorders. On the other hand, compounds of the 5-imino-1,2,4-thiadiazole family are here described, as well as their synthetic procedures, and they may have great application as drug or drug candidates. | 09-06-2012 |